Saudi Arabia Blood Glucose Device Market Size & Forecast 2025–2033

Saudi Arabia Blood Glucose Device Market Outlook (2025–2033)

The Saudi Arabia Blood Glucose Device Market is projected to expand from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, registering a healthy CAGR of 6.78% during the forecast period 2025–2033, according to Renub Research.

Download Free Sample Report

This steady growth trajectory is driven by the country’s rising diabetes prevalence, increasing public awareness around preventive healthcare, expanding insurance coverage, and strong government backing for early diagnosis and self-monitoring of blood glucose. Technological advancements—particularly in continuous glucose monitoring (CGM) systems, smart glucometers, and app-connected devices—are transforming diabetes care and improving patient adherence across Saudi Arabia.

With diabetes recognized as one of the Kingdom’s most pressing public health challenges, blood glucose monitoring devices have become an indispensable component of modern disease management strategies.

Saudi Arabia Blood Glucose Device Market Overview

Blood glucose devices are medical tools used to measure the concentration of glucose in the blood. These devices help individuals with diabetes maintain optimal glycemic control and prevent complications such as hypoglycemia, hyperglycemia, cardiovascular disorders, kidney disease, and neuropathy.

The market includes:

Traditional glucometers

Continuous Glucose Monitoring (CGM) systems

Flash glucose monitoring devices

Consumables such as test strips and lancets

In Saudi Arabia, demand for these devices has increased significantly due to the high incidence of Type 2 diabetes, sedentary lifestyles, dietary changes, and rising obesity levels. Easy availability through hospitals, retail pharmacies, and online channels—combined with public-sector health initiatives—has accelerated adoption in both urban and semi-urban areas.

Key Growth Drivers in the Saudi Arabia Blood Glucose Device Market

1. High and Rising Prevalence of Type 2 Diabetes

Saudi Arabia ranks among the countries with the highest diabetes prevalence globally. Lifestyle factors such as reduced physical activity, calorie-dense diets, and increasing obesity rates have contributed to the rapid rise in Type 2 diabetes cases.

According to international health estimates:

Over 4.27 million people in Saudi Arabia are currently living with diabetes

Nearly 1.86 million individuals remain undiagnosed

The diabetic population is projected to reach 5.6 million by 2030 and 7.5 million by 2045

This growing disease burden has made regular glucose monitoring essential, driving sustained demand for blood glucose devices throughout the forecast period.

2. Technological Advancements and User-Friendly Devices

Technological innovation is reshaping diabetes care in the Kingdom. Modern blood glucose devices now offer:

Real-time glucose tracking

Bluetooth and smartphone connectivity

Cloud-based data sharing with physicians

Smaller, more comfortable sensors

Reduced need for finger-prick testing

CGM systems, in particular, are gaining traction among younger patients, tech-savvy users, and individuals requiring intensive glucose monitoring. In August 2023, a non-invasive wearable glucose sensor received regulatory clearance from the Saudi Food and Drug Authority, highlighting the country’s openness to next-generation diabetes technologies.

Such innovations improve patient compliance, enhance long-term outcomes, and significantly contribute to market expansion.

3. Strong Government Support and Vision 2030 Initiatives

Saudi Arabia’s Vision 2030 places healthcare transformation at the core of national development. The government has launched multiple initiatives aimed at:

Early diabetes screening

Public awareness campaigns

Preventive healthcare promotion

Expansion of digital health infrastructure

Subsidies, insurance reimbursement for diabetes care, and the integration of glucose monitoring in primary healthcare facilities have improved access to monitoring devices. Collaborative programs between public institutions and private healthcare providers are further accelerating market penetration across the Kingdom.

Challenges Facing the Saudi Arabia Blood Glucose Device Market

High Cost of Advanced Monitoring Technologies

Despite their benefits, CGM systems and smart glucometers remain relatively expensive. Not all insurance plans fully cover advanced devices, limiting adoption among low- and middle-income populations. As a result, many patients continue to rely on conventional glucometers despite the advantages offered by newer technologies.

Limited Awareness and Compliance in Rural Areas

Urban centers such as Riyadh, Jeddah, and Dhahran benefit from strong healthcare infrastructure and awareness campaigns. However, rural and remote regions still face challenges related to:

Limited diabetes education

Lower compliance with regular glucose monitoring

Insufficient training on advanced devices

Bridging this urban–rural gap remains critical for achieving nationwide adoption.

Market Insights by Product Type

Test Strips Segment

Test strips remain a vital component of the blood glucose monitoring ecosystem. Widely used with traditional glucometers, they are popular due to their affordability and ease of use—particularly among elderly patients and individuals with Type 2 diabetes.

However, recurring replacement costs can become a financial burden over time. Despite this, consistent demand for test strips continues to support overall market growth.

Market Insights by Application

Type 2 Diabetes Segment

Type 2 diabetes accounts for the majority of glucose monitoring device usage in Saudi Arabia. These patients require regular monitoring to manage medication, lifestyle adjustments, and prevent complications.

Healthcare professionals increasingly encourage home-based monitoring to reduce hospital visits and improve long-term disease management. This trend is expected to sustain strong demand through 2033.

Market Insights by Distribution Channel

Hospital Pharmacies

Hospital pharmacies play a crucial role in introducing newly diagnosed patients to blood glucose monitoring devices. They offer:

Professional guidance

Device training

Subsidized or insured products

Public hospitals, in particular, help ensure equitable access to essential monitoring tools.

Retail Pharmacies

Retail pharmacy chains dominate device distribution across Saudi Arabia. They provide:

Wide brand selection

Competitive pricing

Pharmacist-led education

The expansion of retail pharmacies into smaller cities, along with home delivery and e-commerce services, has significantly enhanced market reach.

Regional Market Analysis

Riyadh

As the capital and largest city, Riyadh represents the largest share of the Saudi blood glucose device market. High healthcare spending, advanced hospitals, and strong technology adoption make it a hub for smart glucose monitoring solutions.

Jeddah

Jeddah’s diverse population and rising lifestyle-related disorders have driven robust demand for both basic glucometers and advanced CGM devices. Wellness programs and digital health initiatives further support market growth.

Dhahran

Dhahran benefits from high disposable incomes, advanced healthcare facilities, and strong private-sector participation. The city shows high adoption of premium glucose monitoring technologies and remains a key regional market.

Market Segmentation

By Product

Test Strips

Lancets

Blood Glucose Meters

By Application

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

By End User

Hospital Pharmacies

Retail Pharmacies

Online Sales

Diabetes Clinics & Centers

By Region

Riyadh

Jeddah

Dhahran

Khobar

Dammam

Others

Competitive Landscape and Key Players

The Saudi Arabia blood glucose device market is moderately competitive, with global and regional players focusing on innovation, partnerships, and regulatory approvals. All major companies are evaluated across five key parameters: company overview, key leadership, recent developments, SWOT analysis, and revenue performance.

Key Players Include:

Abbott Laboratories

Medtronic

Dexcom Inc.

B. Braun Melsungen AG

DarioHealth Corp

Sanofi

Bionime Corporation

Novo Nordisk

Final Thoughts

The Saudi Arabia Blood Glucose Device Market is set for sustained growth through 2033, supported by a rising diabetes burden, proactive government policies, and rapid technological innovation. While affordability and rural accessibility remain challenges, increasing awareness, digital health adoption, and Vision 2030 reforms are creating a favorable environment for long-term expansion.

As self-monitoring becomes central to diabetes management, blood glucose devices—ranging from basic glucometers to advanced CGM systems—will continue to play a vital role in improving patient outcomes and strengthening Saudi Arabia’s healthcare ecosystem.